ID   UBP19_HUMAN             Reviewed;        1318 AA.
AC   O94966; A5PKX8; A6H8U2; B4DGT3; B4DTZ0; E7EN22; E7ETS0; E9PEG8;
AC   Q3KQW4; Q641Q9; Q6NZY8; Q86XV9;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 19;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 19;
DE   AltName: Full=Ubiquitin thioesterase 19;
DE   AltName: Full=Ubiquitin-specific-processing protease 19;
DE   AltName: Full=Zinc finger MYND domain-containing protein 9;
GN   Name=USP19; Synonyms=KIAA0891, ZMYND9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 7).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 6),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 846-1318 (ISOFORM 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 90-1318 (ISOFORM 4).
RC   TISSUE=Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   FUNCTION, TOPOLOGY, AND SUBCELLULAR LOCATION.
RX   PubMed=19465887; DOI=10.1038/embor.2009.69;
RA   Hassink G.C., Zhao B., Sompallae R., Altun M., Gastaldello S.,
RA   Zinin N.V., Masucci M.G., Lindsten K.;
RT   "The ER-resident ubiquitin-specific protease 19 participates in the
RT   UPR and rescues ERAD substrates.";
RL   EMBO Rep. 10:755-761(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH BIRC2/C-IAP1; BIRC3/C-IAP2 AND
RP   XIAP/BIRC4.
RX   PubMed=21849505; DOI=10.1074/jbc.M111.282020;
RA   Mei Y., Hahn A.A., Hu S., Yang X.;
RT   "The USP19 deubiquitinase regulates the stability of c-IAP1 and c-
RT   IAP2.";
RL   J. Biol. Chem. 286:35380-35387(2011).
RN   [10]
RP   FUNCTION, AND LINKAGE SPECIFICITY.
RX   PubMed=22689415; DOI=10.1002/cbic.201200261;
RA   Iphofer A., Kummer A., Nimtz M., Ritter A., Arnold T., Frank R.,
RA   van den Heuvel J., Kessler B.M., Jansch L., Franke R.;
RT   "Profiling ubiquitin linkage specificities of deubiquitinating enzymes
RT   with branched ubiquitin isopeptide probes.";
RL   ChemBioChem 13:1416-1420(2012).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH HIF1A.
RX   PubMed=22128162; DOI=10.1074/jbc.M111.305615;
RA   Altun M., Zhao B., Velasco K., Liu H., Hassink G., Paschke J.,
RA   Pereira T., Lindsten K.;
RT   "Ubiquitin-specific protease 19 (USP19) regulates hypoxia-inducible
RT   factor 1alpha (HIF-1alpha) during hypoxia.";
RL   J. Biol. Chem. 287:1962-1969(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   STRUCTURE BY NMR OF 273-393.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the CS domain of human USP19.";
RL   Submitted (NOV-2004) to the PDB data bank.
CC   -!- FUNCTION: Deubiquitinating enzyme that regulates the degradation
CC       of various proteins. Deubiquitinates and prevents proteasomal
CC       degradation of RNF123 which in turn stimulates CDKN1B ubiquitin-
CC       dependent degradation thereby playing a role in cell
CC       proliferation. Involved in decreased protein synthesis in
CC       atrophying skeletal muscle. Modulates transcription of major
CC       myofibrillar proteins. Also involved in turnover of endoplasmic-
CC       reticulum-associated degradation (ERAD) substrates. Regulates the
CC       stability of BIRC2/c-IAP1 and BIRC3/c-IAP2 by preventing their
CC       ubiquitination. Required for cells to mount an appropriate
CC       response to hypoxia and rescues HIF1A from degradation in a non-
CC       catalytic manner. Plays an important role in 17 beta-estradiol
CC       (E2)-inhibited myogenesis. Decreases the levels of ubiquitinated
CC       proteins during skeletal muscle formation and acts to repress
CC       myogenesis. Exhibits a preference towards 'Lys-63'-linked
CC       Ubiquitin chains. {ECO:0000269|PubMed:19465887,
CC       ECO:0000269|PubMed:21849505, ECO:0000269|PubMed:22128162,
CC       ECO:0000269|PubMed:22689415}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Interacts with RNF123 (By similarity). Interacts with
CC       BIRC2/c-IAP1, BIRC3/c-IAP2 and XIAP/BIRC4. Interacts with HIF1A
CC       (via N-terminus). {ECO:0000250, ECO:0000269|PubMed:21849505,
CC       ECO:0000269|PubMed:22128162}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19465887}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:19465887}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=O94966-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O94966-2; Sequence=VSP_026708, VSP_026709, VSP_026710,
CC                                  VSP_026711;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O94966-3; Sequence=VSP_026712, VSP_026713;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O94966-4; Sequence=VSP_026708, VSP_045891, VSP_026712,
CC                                  VSP_026713;
CC         Note=No experimental confirmation available. Ref.4 (AAH82241)
CC         sequence is in conflict in position: 1251:A->T. {ECO:0000305};
CC       Name=5;
CC         IsoId=O94966-5; Sequence=VSP_026709;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=O94966-6; Sequence=VSP_026709, VSP_045891, VSP_026712,
CC                                  VSP_026713;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=O94966-7; Sequence=VSP_047057, VSP_026712, VSP_026713;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI06030.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAI06030.1; Type=Frameshift; Positions=572; Evidence={ECO:0000305};
CC       Sequence=AAI42661.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA74914.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB020698; BAA74914.1; ALT_INIT; mRNA.
DR   EMBL; AK294756; BAG57894.1; -; mRNA.
DR   EMBL; AK300425; BAG62152.1; -; mRNA.
DR   EMBL; AC135506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC048269; AAH48269.1; -; mRNA.
DR   EMBL; BC065909; AAH65909.1; -; mRNA.
DR   EMBL; BC082241; AAH82241.1; -; mRNA.
DR   EMBL; BC106029; AAI06030.1; ALT_SEQ; mRNA.
DR   EMBL; BC142660; AAI42661.1; ALT_INIT; mRNA.
DR   EMBL; BC146752; AAI46753.1; -; mRNA.
DR   CCDS; CCDS43090.1; -. [O94966-1]
DR   CCDS; CCDS56254.1; -. [O94966-5]
DR   CCDS; CCDS56255.1; -. [O94966-6]
DR   CCDS; CCDS56256.1; -. [O94966-7]
DR   RefSeq; NP_001186089.1; NM_001199160.1. [O94966-5]
DR   RefSeq; NP_001186090.1; NM_001199161.1. [O94966-6]
DR   RefSeq; NP_001186091.1; NM_001199162.1. [O94966-7]
DR   RefSeq; NP_006668.1; NM_006677.2. [O94966-1]
DR   RefSeq; XP_005264888.1; XM_005264831.2. [O94966-4]
DR   RefSeq; XP_016861115.1; XM_017005626.1. [O94966-1]
DR   RefSeq; XP_016861122.1; XM_017005633.1. [O94966-3]
DR   UniGene; Hs.255596; -.
DR   UniGene; Hs.734003; -.
DR   PDB; 1WH0; NMR; -; A=273-393.
DR   PDB; 4X3G; X-ray; 2.34 A; C/D=461-474.
DR   PDBsum; 1WH0; -.
DR   PDBsum; 4X3G; -.
DR   ProteinModelPortal; O94966; -.
DR   SMR; O94966; -.
DR   BioGrid; 116078; 77.
DR   IntAct; O94966; 50.
DR   MINT; MINT-4658026; -.
DR   STRING; 9606.ENSP00000401197; -.
DR   MEROPS; C19.024; -.
DR   iPTMnet; O94966; -.
DR   PhosphoSitePlus; O94966; -.
DR   BioMuta; USP19; -.
DR   EPD; O94966; -.
DR   MaxQB; O94966; -.
DR   PaxDb; O94966; -.
DR   PeptideAtlas; O94966; -.
DR   PRIDE; O94966; -.
DR   Ensembl; ENST00000398888; ENSP00000381863; ENSG00000172046. [O94966-1]
DR   Ensembl; ENST00000417901; ENSP00000395260; ENSG00000172046. [O94966-6]
DR   Ensembl; ENST00000434032; ENSP00000401197; ENSG00000172046. [O94966-5]
DR   Ensembl; ENST00000453664; ENSP00000400090; ENSG00000172046. [O94966-7]
DR   GeneID; 10869; -.
DR   KEGG; hsa:10869; -.
DR   UCSC; uc003cvz.5; human. [O94966-1]
DR   CTD; 10869; -.
DR   DisGeNET; 10869; -.
DR   GeneCards; USP19; -.
DR   HGNC; HGNC:12617; USP19.
DR   MIM; 614471; gene.
DR   neXtProt; NX_O94966; -.
DR   OpenTargets; ENSG00000172046; -.
DR   PharmGKB; PA37243; -.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00670000097750; -.
DR   HOGENOM; HOG000074206; -.
DR   HOVERGEN; HBG061889; -.
DR   InParanoid; O94966; -.
DR   KO; K11847; -.
DR   OMA; AMNAHTP; -.
DR   OrthoDB; EOG091G021E; -.
DR   PhylomeDB; O94966; -.
DR   TreeFam; TF106276; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP19; human.
DR   EvolutionaryTrace; O94966; -.
DR   GenomeRNAi; 10869; -.
DR   PRO; PR:O94966; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000172046; -.
DR   CleanEx; HS_USP19; -.
DR   ExpressionAtlas; O94966; baseline and differential.
DR   Genevisible; O94966; HS.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990380; F:Lys48-specific deubiquitinase activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; IEA:Ensembl.
DR   GO; GO:0048642; P:negative regulation of skeletal muscle tissue development; ISS:UniProtKB.
DR   GO; GO:0090068; P:positive regulation of cell cycle process; ISS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0050821; P:protein stabilization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1900037; P:regulation of cellular response to hypoxia; IMP:UniProtKB.
DR   GO; GO:1904292; P:regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; ISS:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IEP:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   Gene3D; 2.60.40.790; -; 2.
DR   InterPro; IPR007052; CS_dom.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR002893; Znf_MYND.
DR   Pfam; PF04969; CS; 2.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF01753; zf-MYND; 1.
DR   SUPFAM; SSF49764; SSF49764; 2.
DR   PROSITE; PS51203; CS; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS01360; ZF_MYND_1; 1.
DR   PROSITE; PS50865; ZF_MYND_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Endoplasmic reticulum; Hydrolase; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome; Repeat;
KW   Thiol protease; Transmembrane; Transmembrane helix;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1318       Ubiquitin carboxyl-terminal hydrolase 19.
FT                                /FTId=PRO_0000080646.
FT   TOPO_DOM      1   1291       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1292   1312       Helical. {ECO:0000255}.
FT   TOPO_DOM   1313   1318       Lumenal. {ECO:0000255}.
FT   DOMAIN      113    202       CS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00547}.
FT   DOMAIN      282    384       CS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00547}.
FT   DOMAIN      497   1214       USP.
FT   ZN_FING     791    833       MYND-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00134}.
FT   ACT_SITE    506    506       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   ACT_SITE   1165   1165       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     100    114       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026708.
FT   VAR_SEQ     193    202       VPMLTWPSLL -> KKPLGTQELVPGLRCQENGQELSPIAL
FT                                EPGPEPHRAKQEARNQKRAQGRGEVGAGAGPGAQAGPSAKR
FT                                AVHLCRGPEGDGSRDDPGPRGDAPPFVADPATQ (in
FT                                isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047057.
FT   VAR_SEQ     202    202       L -> LKKPLGTQELVPGLRCQENGQELSPIALEPGPEPHR
FT                                AKQEARNQKRAQGRGEVGAGAGPGAQAGPSAKRAVHLCRGP
FT                                EGDGSRDDPGPRGDAPPFVADPATQ (in isoform 2,
FT                                isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026709.
FT   VAR_SEQ     389    389       R -> RGA (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045891.
FT   VAR_SEQ     573    574       IV -> RL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026710.
FT   VAR_SEQ     575   1318       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026711.
FT   VAR_SEQ    1244   1298       ASRIWQELEAEEEPVPEGSGPLGPWGPQDWVGPLPRGPTTP
FT                                DEGCLRYFVLGTVA -> GLGPGQAPEVAPTRTAPERFAPP
FT                                VDRPAPTYSNMEEVD (in isoform 3, isoform 4,
FT                                isoform 6 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026712.
FT   VAR_SEQ    1299   1318       Missing (in isoform 3, isoform 4, isoform
FT                                6 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026713.
FT   VARIANT      36     36       D -> H (in dbSNP:rs11552724).
FT                                /FTId=VAR_051528.
FT   CONFLICT    942    942       S -> C (in Ref. 2; BAG57894).
FT                                {ECO:0000305}.
FT   CONFLICT   1041   1041       E -> G (in Ref. 2; BAG62152).
FT                                {ECO:0000305}.
FT   HELIX       276    278       {ECO:0000244|PDB:1WH0}.
FT   STRAND      279    283       {ECO:0000244|PDB:1WH0}.
FT   STRAND      287    292       {ECO:0000244|PDB:1WH0}.
FT   TURN        293    295       {ECO:0000244|PDB:1WH0}.
FT   STRAND      296    302       {ECO:0000244|PDB:1WH0}.
FT   STRAND      312    315       {ECO:0000244|PDB:1WH0}.
FT   STRAND      317    324       {ECO:0000244|PDB:1WH0}.
FT   HELIX       329    334       {ECO:0000244|PDB:1WH0}.
FT   STRAND      344    352       {ECO:0000244|PDB:1WH0}.
FT   TURN        356    358       {ECO:0000244|PDB:1WH0}.
FT   STRAND      360    363       {ECO:0000244|PDB:1WH0}.
FT   STRAND      365    377       {ECO:0000244|PDB:1WH0}.
FT   STRAND      465    468       {ECO:0000244|PDB:4X3G}.
SQ   SEQUENCE   1318 AA;  145651 MW;  EA9F318D03304AA1 CRC64;
     MSGGASATGP RRGPPGLEDT TSKKKQKDRA NQESKDGDPR KETGSRYVAQ AGLEPLASGD
     PSASASHAAG ITGSRHRTRL FFPSSSGSAS TPQEEQTKEG ACEDPHDLLA TPTPELLLDW
     RQSAEEVIVK LRVGVGPLQL EDVDAAFTDT DCVVRFAGGQ QWGGVFYAEI KSSCAKVQTR
     KGSLLHLTLP KKVPMLTWPS LLVEADEQLC IPPLNSQTCL LGSEENLAPL AGEKAVPPGN
     DPVSPAMVRS RNPGKDDCAK EEMAVAADAA TLVDEPESMV NLAFVKNDSY EKGPDSVVVH
     VYVKEICRDT SRVLFREQDF TLIFQTRDGN FLRLHPGCGP HTTFRWQVKL RNLIEPEQCT
     FCFTASRIDI CLRKRQSQRW GGLEAPAARV GGAKVAVPTG PTPLDSTPPG GAPHPLTGQE
     EARAVEKDKS KARSEDTGLD SVATRTPMEH VTPKPETHLA SPKPTCMVPP MPHSPVSGDS
     VEEEEEEEKK VCLPGFTGLV NLGNTCFMNS VIQSLSNTRE LRDFFHDRSF EAEINYNNPL
     GTGGRLAIGF AVLLRALWKG THHAFQPSKL KAIVASKASQ FTGYAQHDAQ EFMAFLLDGL
     HEDLNRIQNK PYTETVDSDG RPDEVVAEEA WQRHKMRNDS FIVDLFQGQY KSKLVCPVCA
     KVSITFDPFL YLPVPLPQKQ KVLPVFYFAR EPHSKPIKFL VSVSKENSTA SEVLDSLSQS
     VHVKPENLRL AEVIKNRFHR VFLPSHSLDT VSPSDTLLCF ELLSSELAKE RVVVLEVQQR
     PQVPSVPISK CAACQRKQQS EDEKLKRCTR CYRVGYCNQL CQKTHWPDHK GLCRPENIGY
     PFLVSVPASR LTYARLAQLL EGYARYSVSV FQPPFQPGRM ALESQSPGCT TLLSTGSLEA
     GDSERDPIQP PELQLVTPMA EGDTGLPRVW AAPDRGPVPS TSGISSEMLA SGPIEVGSLP
     AGERVSRPEA AVPGYQHPSE AMNAHTPQFF IYKIDSSNRE QRLEDKGDTP LELGDDCSLA
     LVWRNNERLQ EFVLVASKEL ECAEDPGSAG EAARAGHFTL DQCLNLFTRP EVLAPEEAWY
     CPQCKQHREA SKQLLLWRLP NVLIVQLKRF SFRSFIWRDK INDLVEFPVR NLDLSKFCIG
     QKEEQLPSYD LYAVINHYGG MIGGHYTACA RLPNDRSSQR SDVGWRLFDD STVTTVDESQ
     VVTRYAYVLF YRRRNSPVER PPRAGHSEHH PDLGPAAEAA ASQASRIWQE LEAEEEPVPE
     GSGPLGPWGP QDWVGPLPRG PTTPDEGCLR YFVLGTVAAL VALVLNVFYP LVSQSRWR
//
